BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8547506)

  • 1. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus.
    Wilfert CM; Masur H; Gross PA; Kaplan JE; Holmes KK; Phair JP; Simonds RJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S132-3. PubMed ID: 8547506
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in adults and adolescents infected with human immunodeficiency virus.
    Phair JP; Masur H; Gross PA; Holmes KK; Kaplan JE
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S128-9. PubMed ID: 8547504
    [No Abstract]   [Full Text] [Related]  

  • 3. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for failure of prophylaxis for Pneumocystis carinii pneumonia.
    Edge MD; Rimland D
    AIDS; 1999 May; 13(8):991-2. PubMed ID: 10371182
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.
    Esposito S; Bojanin J; Porta A; Cesati L; Gualtieri L; Principi N
    Pediatr Infect Dis J; 2005 Dec; 24(12):1117-20. PubMed ID: 16371882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.
    Razavi B; Lund B; Allen BL; Schlesinger L
    Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
    Chokephaibulkit K; Wanachiwanawin D; Chearskul S; Wanprapa N; Unganont K; Tantinikorn W; Udompunthurak S
    Pediatr Infect Dis J; 1999 Feb; 18(2):147-52. PubMed ID: 10048687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii pneumonia after cessation of secondary prophylaxis in a patient on highly active antiretroviral therapy with a CD4 cell count greater than 200/mm3.
    Lim L ; Street AC; Lewin SR
    AIDS; 2001 Sep; 15(14):1912-3. PubMed ID: 11579267
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprophylaxis for Pneumocystis carinii pneumonia.
    Colebunders R; Denolf D; Verdonck K
    Pediatr Infect Dis J; 1999 Jul; 18(7):662. PubMed ID: 10440453
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa.
    Graham SM
    Lancet; 2002 Dec; 360(9349):1966-8. PubMed ID: 12493279
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
    Held M; Goebel FD
    Eur Respir J; 1996 May; 9(5):868-71. PubMed ID: 8793444
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
    Gupta M; Stephenson K; Gauar S; Frenkel L
    Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe bacterial infections after prophylactic suppression of Pneumocystis carinii in HIV infected patients after CD4 lymphocyte recovery].
    Boix V; Murcia JM; Merino E; Portilla J
    Med Clin (Barc); 2002 Jun; 118(20):796-7. PubMed ID: 12049699
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus.
    Simonds RJ; Hughes WT; Feinberg J; Navin TR
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S44-8. PubMed ID: 8547511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1.
    Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K
    J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.